CRCNS: Crossbeam Transcranial Ultrasound Technology to Stimulate the Deep Brain

总结 对于非侵入性神经调节技术存在许多神经科学和临床应用， 能够以高分辨率到达大脑深处。一个引人注目的临床应用是药物治疗 成瘾是美国公共卫生的一大挑战。在人类中，治疗的神经靶点是1-4 mm 3，因此关键目标是以比目前可用的分辨率更高的分辨率刺激大脑深处 任何非侵入性刺激方式。本研究的目标是开发和实验 高分辨率脑深部经颅超声优化计算模型的验证 刺激（TUS）用于神经科学和临床应用。无创经颅超声刺激 已经在各种动物模型中显示出安全性和空间特异性。然而，目前的系统 没有针对深部脑的高分辨率TUS进行优化。计算模型表明我们可以优化 具有相控阵系统的TUS，可以成对驱动，同时彼此成90°定向并聚焦 到同一个点，叫做“点”这将刺激分辨率提高了一个数量级以上。 大小此外，我们的模型表明，我们可以选择性地刺激神经组织， “捏”或“伸”在这个项目中，我们将进行生物学验证， 由于神经组织对“挤压”或“拉伸”的敏感性，我们验证的建模将是 用于改进涉及优化阵列探针的神经刺激策略。这将允许不 不仅可以选择焦深，而且可以补偿由传播引起的相位像差 穿过头骨优化的硬件和开发的计算模型将被集成 并在颅骨模型实验中得到验证。 相关性（参见说明）： 我们正在开发通过非侵入性治疗神经系统疾病来改善健康的技术。 如成瘾等疾病。

SUMMARY Numerous neuroscience and clinical applications exist for a noninvasive neuromodulation technology that can reach deep in the brain with high resolution. One compelling clinical application is the treatment of drug addiction, a major public health challenge in the US. In humans, the neural targets for treatment are 1-4 mm3, and thus a critical goal is to stimulate deep in the brain with higher resolutions than currently available with any noninvasive stimulation modality. The goal of this research is the development and experimental validation of computational models for optimization of high resolution deep brain transcranial ultrasound stimulation (TUS) for neuroscience and clinical application. Noninvasive transcranial ultrasound stimulation has been shown to be safe and spatially specific in various animal models. However, current systems are not optimized for high resolution TUS of the deep brain. Computational modeling suggests we can optimize TUS with phased array systems that can be driven in pairs while oriented at 90° to each other and focused to the same point, called “crossbeam.” This improves the stimulation resolution by more than an order of magnitude. In addition, our modeling suggests that we can selectively stimulate neural tissue using a “pinch” or “stretch.” In this project, we will perform a biological validation of crossbeam’s improved effectiveness due to the neural tissue’s sensitivity to “pinch” or “stretch.” Our validated modeling will be used to refine a crossbeam neurostimulation strategy involving optimized array probes. This will allow not only choice of focal depth, but also compensation of phase aberrations resulting from the propagation through the skull bone. The optimized hardware and the developed computational models will be integrated with imaging guidance and validated in skull phantom experiments. RELEVANCE (See instructions): We are developing the technology for improving health through the noninvasive treatment of neurological disorders such as addiction.